These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21422817)

  • 41. Suppression of HIV-1 replication by a combination of endonucleolytic ribozymes (RNase P and tRNnase ZL).
    Ikeda M; Habu Y; Miyano-Kurosaki N; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):427-37. PubMed ID: 16838836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.
    Motard J; Rouxel R; Paun A; von Messling V; Bisaillon M; Perreault JP
    PLoS One; 2011; 6(11):e27327. PubMed ID: 22110627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
    Berkhout B; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cis- and trans-acting ribozymes from a human pathogen, hepatitis delta virus.
    Been MD
    Trends Biochem Sci; 1994 Jun; 19(6):251-6. PubMed ID: 8073503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
    Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
    Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of HIV-1 RNA in mammalian nuclei.
    Zhang G; Zapp ML; Yan G; Green MR
    J Cell Biol; 1996 Oct; 135(1):9-18. PubMed ID: 8858159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental study on HDV ribozyme in vitro cleaving the HBV derived RNA fragment].
    Pan GJ; Han JX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):149-52. PubMed ID: 12869998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
    Unwalla H; Banerjea AC
    Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production.
    Noguchi K; Ishibashi K; Miyokawa K; Hokari M; Kanno T; Hirano T; Yamamoto N; Takaku H
    PLoS One; 2012; 7(12):e51393. PubMed ID: 23251516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted cleavage of hepatitis E virus 3' end RNA mediated by hammerhead ribozymes inhibits viral RNA replication.
    Sriram B; Thakral D; Panda SK
    Virology; 2003 Aug; 312(2):350-8. PubMed ID: 12919740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HDV family of self-cleaving ribozymes.
    Riccitelli N; Lupták A
    Prog Mol Biol Transl Sci; 2013; 120():123-71. PubMed ID: 24156943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro.
    Lanchy JM; Szafran QN; Lodmell JS
    Nucleic Acids Res; 2004; 32(15):4585-95. PubMed ID: 15333691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.
    Crisell P; Thompson S; James W
    Nucleic Acids Res; 1993 Nov; 21(22):5251-5. PubMed ID: 8255782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigenomic Hepatitis delta virus ribozymes self-cleave in 18 M formamide.
    Smith JB; Dinter-Gottlieb G
    Nucleic Acids Res; 1991 Mar; 19(6):1285-9. PubMed ID: 1709487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.